Title : Phase II study of docetaxel and celecoxib, a cyclooxygenase-2 inhibitor, in elderly or poor performance status (PS2) patients with advanced non-small cell lung cancer.

Pub. Date : 2008 Nov

PMID : 18978565






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Phase II study of docetaxel and celecoxib, a cyclooxygenase-2 inhibitor, in elderly or poor performance status (PS2) patients with advanced non-small cell lung cancer. Docetaxel taste 2 receptor member 64 pseudogene Homo sapiens